Louis Lehot on Biotech IPOs – 'Biotech could have a great fourth quarter'
September 4, 2024
Bloomberg Law
Foley & Lardner LLP partner Louis Lehot offered insight on the biotech industry’s upcoming initial public offerings in the Bloomberg Law article, “Biotech IPO Hopefuls Ready Burst of Debuts After Rough Stretch.”
“Biotech could have a great fourth quarter, we have a great pipeline,” Lehot commented, as several biotech companies look to reignite the sector with upcoming IPOs. “Biotech IPOs are here and ready to put money to work.”
(Subscription required)
People
Related News
June 12, 2026
In the News
Chris Babcock and Chris Converse on Wave of Companies Moving to Texas
Foley & Lardner LLP partners Chrisopher Babcock and Chris Converse commented on the widening trend of companies reincorporating to Texas in the Houston Business Journal article, “Texas law changes could spark wave of corporate redomestication proposals."
June 10, 2026
In the News
Louis Lehot and Patrick Daugherty Publish on Revitalizing IPO Markets
Foley & Lardner LLP partners Louis Lehot and Patrick Daugherty authored the Westlaw Today article, How to Make IPOs Great Again, analyzing SEC public market reform proposals.
June 8, 2026
In the News
Aaron Tantleff Authors Article on Stadium Technology – 'Arenas are no longer simply places to watch games'
Foley & Lardner LLP partner Aaron Tantleff authored the Sports Business Journal article, “Stadium tech in 2026: How venues are monetizing first-party data and in-venue fan moments.”